We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Corticosteroid Administration and Treatment Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease—Reply

Peter K. Lindenauer, MD, MSc; Penelope S. Pekow, PhD; Michael B. Rothberg, MD, MPH
JAMA. 2010;304(14):1554-1556. doi:10.1001/jama.2010.1439.
Text Size: A A A
Published online


In Reply: Dr Chang and colleagues describe several concerns, including that residual confounding may account for the observed differences in mortality in the propensity-matched sample, that patients whose corticosteroid regimen was changed from low-dose oral to high-dose intravenous should have been counted as treatment failures, and that the intention-to-treat analytic strategy was inappropriate. We acknowledge that the lack of information about prehospital treatment and residual confounding by indication, in which sicker patients (regardless of prior treatment with steroids in the ambulatory setting) would be more likely to be treated with high doses of steroids, is a limitation to our study. This concern led us to pursue an adaptation of the instrumental variable approach, which bypasses confounding by indication at the patient level. In this analysis, the effect estimate for a 10% increase in the proportion of patients receiving low-dose oral therapy in place of high-dose intravenous therapy was 1.00 (95% confidence interval, 0.97-1.03), suggesting little if any effect of steroid dosing on the primary outcome.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




October 13, 2010
Kwok Chiu Chang, MBBS, MSc; Chi Chiu Leung, MBBS; Fuk Yip Kong, MBBS
JAMA. 2010;304(14):1554-1556. doi:10.1001/jama.2010.1438.
October 13, 2010
Jerry A. Krishnan, MD, PhD; Richard A. Mularski, MD, MSHS, MCR
JAMA. 2010;304(14):1554-1556. doi:10.1001/jama.2010.1440.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.